Lv31
380 积分 2022-08-20 加入
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer
5个月前
已完结
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
9个月前
已完结
Colorectal cancer
9个月前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
10个月前
已完结
Rare tumors: a blue ocean of investigation
1年前
已完结
Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancer
1年前
已完结
Therapeutic landscape and future direction of metastatic colorectal cancer
1年前
已完结
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)
1年前
已完结
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation
2年前
已完结
Efficacy and safety of vitamin D3 in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials
皖公网安备34019202002308
